• Calcitriol Workflows for Bone Homeostasis Research

  2026-08-11

  Build stronger bone, immune, and signaling assays with Calcitriol, the direct VDR-active metabolite of vitamin D3. This guide translates NFIA-centered bone biology into practical dose-response, differentiation, cytokine, and Hedgehog pathway workflows while highlighting controls and troubleshooting decisions.

• Adefovir Pharmacokinetics in OAT1 Cocktail Phenotyping

  2026-08-11

  The 2024 reference study used population pharmacokinetic modeling to explain why adefovir exposure increased modestly in a transporter cocktail without evidence of altered renal OAT1 elimination. Its results refine the interpretation of adefovir renal clearance as a phenotyping metric and distinguish absorption or prodrug-conversion effects from transporter-mediated drug interactions.

• SmD2 Acetylation Links Splicing to PARP Sensitivity

  2026-08-10

  This 2024 Nature Communications study identifies SmD2 acetylation as a regulatory connection between core spliceosome activity, BRCA1/FANC cassette exons, and PARP inhibitor sensitivity in hepatocellular carcinoma. Its findings support combining HDAC inhibition with PARP blockade as a strategy for HCC models with impaired DNA repair.

• Mouse Neutrophil Cell Isolation Kit for Assays

  2026-08-09

  The Mouse Neutrophil Cell Isolation Kit supports high-purity, low-perturbation neutrophil preparation from mouse tissues. This guide explains how negative selection can improve assay interpretation in functional immunology and neutrophil-targeted nanovaccine studies.

• TAK-715 and the Next Logic of p38α Inhibition

  2026-08-08

  TAK-715 offers translational researchers a selective way to interrogate p38α biology, while emerging kinase–phosphatase insights suggest a more rigorous framework for connecting target engagement with durable anti-inflammatory responses.

• Crizotinib hydrochloride in Gastric Cancer Assembloids

  2026-08-07

  Crizotinib hydrochloride enables paired testing of ALK, c-Met, and ROS1-linked signaling in tumor organoids and stromal-integrated gastric cancer assembloids. This workflow helps distinguish direct tumor-cell sensitivity from microenvironment-mediated resistance while preserving practical controls for dosing, phosphorylation assays, viability measurements, and transcriptomic follow-up.

• hiPSC-Derived Sensory Neurons Model HSV-1 Latency and Reacti

  2026-08-07

  This study establishes a scalable system using human inducible pluripotent stem cell (hiPSC)-derived sensory neurons to model latent infection and reactivation of herpes simplex virus 1 (HSV-1). The model enables investigation of human neuron-intrinsic mechanisms of HSV-1 latency, offering a valuable platform for antiviral research and therapeutic development.

• Adefovir (GS-0393): Translational Leverage in HBV Research

  2026-08-06

  This thought-leadership article explores the molecular mechanism, experimental applications, and translational relevance of Adefovir (GS-0393) in hepatitis B virus research. Integrating recent clinical and bench research, it delivers strategic guidance for researchers advancing HBV antiviral therapies, highlights APExBIO’s product leadership, and provides detailed protocol parameters for robust, reproducible outcomes.

• Torin2: A Potent mTOR Inhibitor for Cancer Research Applicat

  2026-08-06

  Torin2 is a highly selective, orally available mTOR inhibitor with sub-nanomolar potency. It enables robust inhibition of mTOR signaling and has demonstrated efficacy in apoptosis assays and tumor models. Its superior selectivity and bioavailability make it a key tool for dissecting PI3K/Akt/mTOR pathways in cancer research.

• Plant Cell Lysis Buffer for WB and IP: Protocols & Real-Worl

  2026-08-05

  Unlock high-efficiency protein extraction from challenging plant tissues with Plant Cell Lysis Buffer for WB and IP. This guide provides actionable protocols, troubleshooting strategies, and research-driven context for robust Western blotting and immunoprecipitation workflows.

• Lamotrigine in Cardiotoxicity Risk Modeling: A Systems Appro

  2026-08-05

  Explore how Lamotrigine, a sodium channel blocker and 5-HT inhibitor, advances cardiotoxicity risk modeling using iPSC-derived cardiomyocytes. This article uniquely integrates transcriptomic data and mechanistic insights for next-generation assay design.

• TRPV1+ Nerve Stimulation Suppresses Systemic Inflammation vi

  2026-08-04

  Song et al. (2025) reveal that targeted stimulation of TRPV1+ peripheral somatosensory nerves at the nape activates a somato-autonomic reflex, rapidly suppressing systemic inflammation via sympathetic and parasympathetic pathways. This neural circuit-based anti-inflammatory mechanism provides new insight for neuro-immune research and therapeutic strategies.

• PR-619: Advancing Translational Research in DUB Inhibition

  2026-08-04

  This thought-leadership article explores the mechanistic and translational power of PR-619, a broad-spectrum deubiquitylating enzymes inhibitor, with actionable guidance for researchers in cancer biology, neurodegenerative models, and autophagy pathway analysis. Integrating new insights, competitive context, and best-practice protocols, it positions PR-619 as a critical tool for robust, clinically relevant discoveries—while transparently addressing its limitations and future potential.

• Leucomycin (Kitasamycin): Mechanism, Evidence & Application

  2026-08-03

  Leucomycin (kitasamycin) is a well-characterized 16-membered macrolide antibiotic with potent activity against Gram-positive bacteria. Its mechanism involves binding to bacterial 50S ribosomes, resulting in translational inhibition. Evidence supports its benchmark use in resistance and antibacterial drug discovery assays.

• YM 58483 (BTP2) in SOCE Blockade: Fibrosis & T Cell Assay To

  2026-08-03

  YM 58483 (BTP2) delivers potent, selective SOCE inhibition, empowering researchers to dissect calcium-mediated signaling in immune modulation and early-stage fibrosis. Recent studies have established its value in both mechanistic discovery and translational fibrosis models, making it a versatile tool for immunology and tissue pathology research.

16510 records 1/1101 page Next 12345 下5页 Last page